These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11342440)

  • 1. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo.
    Koh CY; Blazar BR; George T; Welniak LA; Capitini CM; Raziuddin A; Murphy WJ; Bennett M
    Blood; 2001 May; 97(10):3132-7. PubMed ID: 11342440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK inhibitory-receptor blockade for purging of leukemia: effects on hematopoietic reconstitution.
    Koh CY; Raziuddin A; Welniak LA; Blazar BR; Bennett M; Murphy WJ
    Biol Blood Marrow Transplant; 2002; 8(1):17-25. PubMed ID: 11846352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2.
    Vahlne G; Lindholm K; Meier A; Wickström S; Lakshmikanth T; Brennan F; Wilken M; Nielsen R; Romagné F; Wagtmann NR; Kärre K; Johansson MH
    Eur J Immunol; 2010 Mar; 40(3):813-23. PubMed ID: 20039300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
    Routes JM; Ryan JC; Ryan S; Nakamura M
    Int Immunol; 2001 Oct; 13(10):1301-7. PubMed ID: 11581175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
    Das A; Saxena RK
    Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
    Michaëlsson J; Achour A; Rölle A; Kärre K
    J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
    Held W; Kunz B
    Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors.
    Lindberg J; Martín-Fontecha A; Höglund P
    Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells.
    Held W; Roland J; Raulet DH
    Nature; 1995 Jul; 376(6538):355-8. PubMed ID: 7630404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
    Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
    J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors.
    Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P
    J Exp Med; 2001 Nov; 194(10):1519-30. PubMed ID: 11714758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice.
    Salcedo M; Diehl AD; Olsson-Alheim MY; Sundbäck J; Van Kaer L; Kärre K; Ljunggren HG
    J Immunol; 1997 Apr; 158(7):3174-80. PubMed ID: 9120271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
    Fahlén L; Lendahl U; Sentman CL
    J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
    Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
    J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of Ly49 receptor expression by developing natural killer cells.
    Dorfman JR; Raulet DH
    J Exp Med; 1998 Feb; 187(4):609-18. PubMed ID: 9463411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.
    Regunathan J; Chen Y; Wang D; Malarkannan S
    Blood; 2005 Jan; 105(1):233-40. PubMed ID: 15328154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade.
    Koh CY; Ortaldo JR; Blazar BR; Bennett M; Murphy WJ
    Blood; 2003 Dec; 102(12):4067-75. PubMed ID: 12893752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.